Endoscopic Management of Fistulas Related to Sleeve Gastrectomy With Double Pigtail Stents According to the BARTOLI Technique (bartoli)

January 17, 2023 updated by: Centre Hospitalier Universitaire, Amiens

Endoscopic Management of Fistulas Related to Sleeve Gastrectomy With Double Pigtail Stents According to the BARTOLI Technique : an Interventional Multicentric and Prospective Study.

Obesity is a major health problem in western countries, and sleeve gastrectomy has proven its effectiveness on weight loss and improvement of comorbidities related to obesity. The main complication is the occurrence of upper fistula (2%), and may be responsible of several deaths.

There is no consensus on medical, radiological and surgical management of fistula. It depends on the resources of each center and is based on a low level evidence The inconstant efficacy of the endoscopic treatment by closing fistula (digestive stents, clips, glue) motivates a new endoscopic approach. It consists of an internal drainage of the collection by using double pigtail stents through the fistulous orifice.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Partially or fully covered stents are the most used method, but are not supported by any comparative studies. Their results are inconstant and the closure rate is estimated between 15 and 100%, with a hazardous median healing time. This method is associated with frequent complications, such as spontaneous migrations, impactions or ulcerations responsible for potentially fatal hematemesis. The preliminary results of using OTSC clips (OVESCO®) seem encouraging, but this technique requires external drainage to obtain a collection free from infection. A new approach is to perform an internal drainage of the peri-orificial collection by using double pigtail stents through the fistulous orifice and to direct the fistula closure from the outside to the inside. This endoscopic treatment, combined with nutritional support and initial antibiotic therapy, allows rapid weaning of external drainage and short healing times. CT and endoscopic evaluation are needed at the sixth week for stents removal in the event of a favorable evolution. In the opposite case, a second endoscopic treatment is performed. In case of unfavorable evolution, a radical surgical treatment, in the absence of endoscopic alternative, will be achieved.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Picardie
      • Amiens, Picardie, France, 80000
        • Centre Hospitalier Universitaire d'Amiens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any major patient hospitalized for a symptomatic fistula after sleeve gastrectomy, outside the exclusion criteria, is eligible.
  • Free, informed and signed consent
  • Affiliation to the social security system

Exclusion Criteria:

  • Other surgery than Sleeve gastrectomy
  • Fistula located at a site other than the upper pole of the staple line
  • Fistulization on the upper diaphragmatic floor
  • Fistulous orifice larger than 25 mm
  • Pregnancy
  • Patient under guardianship or curators or deprived of public law

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: endoscopy
In the case of a well-organized abscessed collection responsible for sepsis instability, or poorly organized collection, an external drainage is carried out, by a radiological or a surgical way. The endoscopy is performed 7 days later. If there is no hemodynamic instability and in presence of a well-organized abscessed collection, a first-line endoscopy is carried out. After laying 2 double pig tail stents, the external drainage is removed 2 to 7 days later.
In the case of a well-organized abscessed collection responsible for sepsis instability, or poorly organized collection, an external drainage is carried out, by a radiological or a surgical way. The endoscopy is performed 7 days later. If there is no hemodynamic instability and in presence of a well-organized abscessed collection, a first-line endoscopy is carried out. After laying 2 double pig tail stents, the external drainage is removed 2 to 7 days later.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Fistula Healing at week 18
Time Frame: week 18 after endoscopy
Number of Participants with Healing at week 18
week 18 after endoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Fistula Healing at week 6
Time Frame: week 6 after endoscopy
Number of Participants with Fistula Healing at week 6
week 6 after endoscopy
Number of Participants with Fistula Healing at week 12
Time Frame: week 12 after endoscopy
Number of Participants with Fistula Healing at week 12
week 12 after endoscopy
Number of Participants with Fistula delay
Time Frame: up to week 18 after endoscopy
Number of Participants with Fistula delay
up to week 18 after endoscopy
Number of Participants with gastric stenosis
Time Frame: up to week 18 after endoscopy
Number of Participants with gastric stenosis
up to week 18 after endoscopy
Measure of length of hospital stay
Time Frame: up to week 18 after endoscopy
Average total length of hospital stay
up to week 18 after endoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sami Hakim, MD, CHU Amiens
  • Principal Investigator: Lionel Rebibo, MD, Hopital Bichat, Paris
  • Principal Investigator: Jean-Christophe Duchmann, MD, Centre Hospitalier Compiegne
  • Principal Investigator: Jonathan Levy, MD, Clinique des Cèdres Chât Alliez, Cornebarrieu
  • Principal Investigator: Jean-François Bourgaux, MD, CHRU Nîmes
  • Principal Investigator: Ion Donici, MD, CHRU Nîmes
  • Principal Investigator: Vincent Quentin, MD, CH Saint Brieux
  • Principal Investigator: Fabien Fumex, MD, Hopital Jean Mermoz, Lyon
  • Principal Investigator: Gaetan Singier, MD, Hopital Jean Mermoz, Lyon
  • Principal Investigator: Cécile Gomercic, MD, CHU Nice
  • Principal Investigator: Antonio Iannelli, MD, CHU Nice
  • Principal Investigator: Claire Blanchard, MD, CHU Nantes
  • Principal Investigator: Timothée Wallenhorst, MD, Chu Rennes
  • Principal Investigator: Damien Bergeat, MD, Chu Rennes
  • Principal Investigator: Davide Mazza, MD, CH Toulon
  • Principal Investigator: Stéphane Koch, MD, CHRU Besançon
  • Principal Investigator: Nicolas Bouviez, MD, CHRU Besançon
  • Principal Investigator: Antoine Soprani, MD, Clinique PARIS-BERCY
  • Principal Investigator: Clément Subtil, MD, CHU Bordeaux
  • Principal Investigator: Ulriikka Chaput, MD, Hopital Saint Antoine, Paris
  • Principal Investigator: Jérome Rivory, MD, Hopital Edouard Herriot - Lyon
  • Principal Investigator: Maud Robert, MD, Hopital Edouard Herriot - Lyon
  • Principal Investigator: Franck Cholet, MD, CHU Brest
  • Principal Investigator: Jérémie Thereaux, MD, CHU Brest
  • Principal Investigator: Jean-Christophe Valats, MD, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

November 1, 2021

Study Registration Dates

First Submitted

July 18, 2019

First Submitted That Met QC Criteria

August 6, 2019

First Posted (Actual)

August 8, 2019

Study Record Updates

Last Update Posted (Actual)

January 18, 2023

Last Update Submitted That Met QC Criteria

January 17, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PI2018_843_0017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fistula

Clinical Trials on endoscopy

3
Subscribe